• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma.

作者信息

Baiocchi Leonardo, Francis Heather, Alpini Gianfranco

机构信息

Unit of Hepatology, Tor Vergata University, Rome, Italy.

Division of Gastroenterology and Hepatology, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA.

出版信息

J Clin Transl Hepatol. 2022 Oct 28;10(5):783-785. doi: 10.14218/JCTH.2022.00229. Epub 2022 Jul 29.

DOI:10.14218/JCTH.2022.00229
PMID:36304496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9547249/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf1/9547249/483ecdcea436/JCTH-10-0783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf1/9547249/483ecdcea436/JCTH-10-0783-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/baf1/9547249/483ecdcea436/JCTH-10-0783-g001.jpg

相似文献

1
Therapeutic Use of Viruses: Newcastle Disease Virus HK84 Oncolytic Treatment for Hepatocellular Carcinoma.病毒的治疗用途：新城疫病毒HK84对肝细胞癌的溶瘤治疗
J Clin Transl Hepatol. 2022 Oct 28;10(5):783-785. doi: 10.14218/JCTH.2022.00229. Epub 2022 Jul 29.
2
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling.野生型新城疫病毒HK84对与I型干扰素信号激活相关的肝细胞癌的溶瘤活性
J Clin Transl Hepatol. 2022 Apr 28;10(2):284-296. doi: 10.14218/JCTH.2021.00284. Epub 2021 Nov 19.
3
Newcastle Disease Virus/HK84: Next Potential Star for Targeted Immunotherapy of Hepatocellular Carcinoma?新城疫病毒/HK84：会是肝细胞癌靶向免疫治疗的下一颗潜在之星吗？
J Clin Transl Hepatol. 2022 Apr 28;10(2):179-180. doi: 10.14218/JCTH.2021.00553. Epub 2022 Mar 2.
4
A Novel Chimeric Oncolytic Virus Vector for Improved Safety and Efficacy as a Platform for the Treatment of Hepatocellular Carcinoma.一种新型嵌合溶瘤病毒载体，可提高安全性和疗效，作为治疗肝细胞癌的平台。
J Virol. 2018 Nov 12;92(23). doi: 10.1128/JVI.01386-18. Print 2018 Dec 1.
5
Targeting aerobic glycolysis by dichloroacetate improves Newcastle disease virus-mediated viro-immunotherapy in hepatocellular carcinoma.二氯乙酸盐通过靶向有氧糖酵解增强新城疫病毒介导的肝癌病毒免疫治疗。
Br J Cancer. 2020 Jan;122(1):111-120. doi: 10.1038/s41416-019-0639-7. Epub 2019 Dec 10.
6
Oncolytic Newcastle disease virus expressing chimeric antibody enhanced anti-tumor efficacy in orthotopic hepatoma-bearing mice.表达嵌合抗体的溶瘤新城疫病毒增强了原位肝癌荷瘤小鼠的抗肿瘤疗效。
J Exp Clin Cancer Res. 2015 Dec 21;34:153. doi: 10.1186/s13046-015-0271-1.
7
Newcastle disease virus (NDV): brief history of its oncolytic strains.新城疫病毒（NDV）：其溶瘤毒株的简史。
J Clin Virol. 2000 Feb;16(1):1-15. doi: 10.1016/s1386-6532(99)00072-4.
8
Genetically engineered Newcastle disease virus expressing interleukin-2 and TNF-related apoptosis-inducing ligand for cancer therapy.用于癌症治疗的表达白细胞介素-2和肿瘤坏死因子相关凋亡诱导配体的基因工程新城疫病毒。
Cancer Biol Ther. 2014 Sep;15(9):1226-38. doi: 10.4161/cbt.29686. Epub 2014 Jun 27.
9
Newcastle disease virus strain AF2240 as an oncolytic virus: A review.作为溶瘤病毒的新城疫病毒AF2240株综述
Acta Trop. 2018 Jul;183:126-133. doi: 10.1016/j.actatropica.2018.04.007. Epub 2018 Apr 4.
10
Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.重组溶瘤新城疫病毒在间变性甲状腺癌细胞中显示抗肿瘤活性。
BMC Cancer. 2018 Jul 18;18(1):746. doi: 10.1186/s12885-018-4522-3.

引用本文的文献

1
Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis.溶瘤病毒塞内卡病毒A通过诱导细胞周期停滞和凋亡抑制肝细胞癌的增殖与生长。
J Clin Transl Hepatol. 2024 Aug 28;12(8):713-725. doi: 10.14218/JCTH.2024.00125. Epub 2024 Jun 20.

本文引用的文献

1
Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling.野生型新城疫病毒HK84对与I型干扰素信号激活相关的肝细胞癌的溶瘤活性
J Clin Transl Hepatol. 2022 Apr 28;10(2):284-296. doi: 10.14218/JCTH.2021.00284. Epub 2021 Nov 19.
2
Evidence-Based Management of Hepatocellular Carcinoma: Systematic Review and Meta-analysis of Randomized Controlled Trials (2002-2020).基于证据的肝细胞癌管理：系统评价和随机对照试验的荟萃分析 (2002-2020)。
Gastroenterology. 2021 Sep;161(3):879-898. doi: 10.1053/j.gastro.2021.06.008. Epub 2021 Jun 12.
3
Advances in immunotherapy for hepatocellular carcinoma.
肝细胞癌的免疫治疗进展。
Nat Rev Gastroenterol Hepatol. 2021 Aug;18(8):525-543. doi: 10.1038/s41575-021-00438-0. Epub 2021 Apr 13.
4
The pros and cons of interferons for oncolytic virotherapy.干扰素在溶瘤病毒治疗中的利弊。
Cytokine Growth Factor Rev. 2020 Dec;56:49-58. doi: 10.1016/j.cytogfr.2020.07.002. Epub 2020 Jul 3.
5
Oncolytic virotherapy in hepato-bilio-pancreatic cancer: The key to breaking the log jam?肝胰胆癌的溶瘤病毒疗法：打破僵局的关键？
Cancer Med. 2020 May;9(9):2943-2959. doi: 10.1002/cam4.2949. Epub 2020 Mar 4.
6
SK-Hep1: not hepatocellular carcinoma cells but a cell model for liver sinusoidal endothelial cells.SK-Hep1：并非肝癌细胞，而是肝窦内皮细胞的一种细胞模型。
Int J Clin Exp Pathol. 2018 May 1;11(5):2931-2938. eCollection 2018.
7
Breaking Therapy Resistance: An Update on Oncolytic Newcastle Disease Virus for Improvements of Cancer Therapy.突破治疗耐药性：溶瘤新城疫病毒改善癌症治疗的最新进展
Biomedicines. 2019 Aug 30;7(3):66. doi: 10.3390/biomedicines7030066.
8
Oncolytic Viruses in Cancer Treatment: A Review.溶瘤病毒在癌症治疗中的应用：综述。
JAMA Oncol. 2017 Jun 1;3(6):841-849. doi: 10.1001/jamaoncol.2016.2064.
9
Effect and safety of interferon for hepatocellular carcinoma: a systematic review and meta-analysis.干扰素治疗肝细胞癌的疗效和安全性：系统评价和荟萃分析。
PLoS One. 2013 Sep 17;8(9):e61361. doi: 10.1371/journal.pone.0061361. eCollection 2013.
10
Phase I trial of intravenous administration of PV701, an oncolytic virus, in patients with advanced solid cancers.溶瘤病毒PV701静脉给药用于晚期实体癌患者的I期试验。
J Clin Oncol. 2002 May 1;20(9):2251-66. doi: 10.1200/JCO.2002.08.042.